Abdoul Karim Sangare
Research Subjects
Abdoul Karim Sangare has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Bourema Kouriba
Malaria Research and Training Center, Parasitology Section, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
3 shared publications - Abderrhamane Maiga
Centre d’Infectiologie Charles Mérieux du Mali, BPE2283 Bamako, Mali
2 shared publications - Alexandra Rehn
Bundeswehr Institute of Microbiology, Munich, Germany
2 shared publications - Angela Duerr
Bundeswehr Institute of Microbiology, D-80937 Munich, Germany
2 shared publications - Asli Heitzer
Bundeswehr Institute of Microbiology, D-80937 Munich, Germany
2 shared publications - Brehima Traore
Centre d’Infectiologie Charles Mérieux, Bamako BPE2283, Mali
2 shared publications
Latest Publications
- Open Access
- 3 April 2026
- Published by AccScience Publishing in Microbes & Immunity
- p. 025380102
Seroprevalence of autoantibodies to nuclear and phospholipid antigens in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali
Coronavirus disease 2019 (COVID-19) has been associated with the production of autoantibodies and the development of autoimmune disease. However, the prevalence of autoantibodies during the early wave of the pandemic is not known in Mali. We sought to assess the seroprevalence of autoantibodies in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali. A retrospective cross-sectional study was conducted from April to July 2020 at the Charles Mérieux Centre of Infectiology, Bamako. We screened 1,271 individuals suspected of having COVID-19. Samples were tested for SARS-CoV-2 antibodies. Overall, 19% of screened individuals were seropositive for anti–SARS-CoV-2 immunoglobulin G and/or M. Subsequently, ninety serum specimens were selected and analyzed for the detection of autoantibodies using an IDS-iSYS chemiluminescence immunoassay. We found a seroprevalence of 32.22% for autoantibodies. Seroprevalence was similar in women (18.89%) and men (13.33%, p = 0.25). The largest age group in this autoantibody seroprevalence study was 41–60 years (44%). Seroprevalence was higher for antinuclear antibodies and anti-beta-2 glycoprotein IgG, at 20% each. However, it was lower for anti-beta-2 glycoprotein I IgM, anti-cardiolipin IgG, and anti-cardiolipin IgM, and anti-myeloperoxidase antibodies, at 7%. The high seroprevalence of autoantibodies could contribute to the onset or the reactivation of autoimmune disorders during coronavirus infection.
- 3 April 2026
- Published by AccScience Publishing in Microbes & Immunity
- p. 025380102
Open AccessSeroprevalence of autoantibodies to nuclear and phospholipid antigens in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali
Coronavirus disease 2019 (COVID-19) has been associated with the production of autoantibodies and the development of autoimmune disease. However, the prevalence of autoantibodies during the early wave of the pandemic is not known in Mali. We sought to assess the seroprevalence of autoantibodies in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali. A retrospective cross-sectional study was conducted from April to July 2020 at the Charles Mérieux Centre of Infectiology, Bamako. We screened 1,271 individuals suspected of having COVID-19. Samples were tested for SARS-CoV-2 antibodies. Overall, 19% of screened individuals were seropositive for anti–SARS-CoV-2 immunoglobulin G and/or M. Subsequently, ninety serum specimens were selected and analyzed for the detection of autoantibodies using an IDS-iSYS chemiluminescence immunoassay. We found a seroprevalence of 32.22% for autoantibodies. Seroprevalence was similar in women (18.89%) and men (13.33%, p = 0.25). The largest age group in this autoantibody seroprevalence study was 41–60 years (44%). Seroprevalence was higher for antinuclear antibodies and anti-beta-2 glycoprotein IgG, at 20% each. However, it was lower for anti-beta-2 glycoprotein I IgM, anti-cardiolipin IgG, and anti-cardiolipin IgM, and anti-myeloperoxidase antibodies, at 7%. The high seroprevalence of autoantibodies could contribute to the onset or the reactivation of autoimmune disorders during coronavirus infection.
- Open Access
First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region
We are currently facing a pandemic of COVID-19, caused by a spillover from an animal-originating coronavirus to humans occurring in the Wuhan region of China in December 2019. From China, the virus has spread to 188 countries and regions worldwide, reaching the Sahel region on 2 March 2020. Since whole genome sequencing (WGS) data is very crucial to understand the spreading dynamics of the ongoing pandemic, but only limited sequencing data is available from the Sahel region to date, we have focused our efforts on generating the first Malian sequencing data available. Screening 217 Malian patient samples for the presence of SARS-CoV-2 resulted in 38 positive isolates, from which 21 whole genome sequences were generated. Our analysis shows that both the early A (19B) and the later observed B (20A/C) clade are present in Mali, indicating multiple and independent introductions of SARS-CoV-2 to the Sahel region.
Open AccessFirst Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region
We are currently facing a pandemic of COVID-19, caused by a spillover from an animal-originating coronavirus to humans occurring in the Wuhan region of China in December 2019. From China, the virus has spread to 188 countries and regions worldwide, reaching the Sahel region on 2 March 2020. Since whole genome sequencing (WGS) data is very crucial to understand the spreading dynamics of the ongoing pandemic, but only limited sequencing data is available from the Sahel region to date, we have focused our efforts on generating the first Malian sequencing data available. Screening 217 Malian patient samples for the presence of SARS-CoV-2 resulted in 38 positive isolates, from which 21 whole genome sequences were generated. Our analysis shows that both the early A (19B) and the later observed B (20A/C) clade are present in Mali, indicating multiple and independent introductions of SARS-CoV-2 to the Sahel region.
- Open Access
First phylogenetic analysis of Malian SARS-CoV-2 sequences provide molecular insights into the genomic diversity of the Sahel region
We are currently facing a pandemic of COVID-19, caused by a spillover from an animal-originating coronavirus to humans occuring in the Wuhan region, China, in December 2019. From China the virus has spread to 188 countries and regions worldwide, reaching the Sahel region on the 2nd of March 2020. Since whole genome sequencing (WGS) data is very crucial to understand the spreading dynamics of the ongoing pandemic, but only limited sequence data is available from the Sahel region to date, we have focused our efforts on generating the first Malian sequencing data available. Screening of 217 Malian patient samples for the presence of SARS-CoV-2 resulted in 38 positive isolates from which 21 whole genome sequences were generated. Our analysis shows that both, the early A (19B) and the fast evolving B (20A/C) clade, are present in Mali indicating multiple and independent introductions of the SARS-CoV-2 to the Sahel region.
Open AccessFirst phylogenetic analysis of Malian SARS-CoV-2 sequences provide molecular insights into the genomic diversity of the Sahel region
We are currently facing a pandemic of COVID-19, caused by a spillover from an animal-originating coronavirus to humans occuring in the Wuhan region, China, in December 2019. From China the virus has spread to 188 countries and regions worldwide, reaching the Sahel region on the 2nd of March 2020. Since whole genome sequencing (WGS) data is very crucial to understand the spreading dynamics of the ongoing pandemic, but only limited sequence data is available from the Sahel region to date, we have focused our efforts on generating the first Malian sequencing data available. Screening of 217 Malian patient samples for the presence of SARS-CoV-2 resulted in 38 positive isolates from which 21 whole genome sequences were generated. Our analysis shows that both, the early A (19B) and the fast evolving B (20A/C) clade, are present in Mali indicating multiple and independent introductions of the SARS-CoV-2 to the Sahel region.